The PROTAC interacted with KRAS G12C in vitro, induced dimerization with CRBN, and degraded GFP-KRAS G12C in cells when overexpressed, but failed to degrade endogenous KRAS G12C in lung cancer cells [25]. The gene discussed is KRAS; the disease is lung carcinoma.